Edwards’ CEO Addresses Senate Committee On Preserving And Strengthening Medical Device Innovation In The U.S.
WASHINGTON, March 24, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced that Edwards’ Chairman and CEO Michael A. Mussallem today served as an invited expert panelist on behalf of the Advanced Medical Technology Association (AdvaMed) at the United States Senate Health, Education, Labor and Pensions Committee hearing on “Continuing America’s Leadership: Advancing Research and Development for Patients.”
“As medical technology innovators, it’s our passion and mission to continue developing better solutions to improve the lives of patients,” said Mussallem. “To maximize the impact of this work, it is imperative that we forge a path toward revitalizing the medical technology ecosystem in the United States. Continued innovation is vital to improving clinical outcomes, enhancing patients’ quality of life and bringing increased value to the healthcare system.”
Mussallem noted collaborative engagement and significant progress by the U.S. Food & Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) in better understanding and improving the predictability and approval timelines for future generations of medical devices.
He also addressed opportunities to further reduce barriers in regulatory approval and reimbursement, in order to help promote America’s continued worldwide leadership in medical device development and also to support innovation. His comments focused on three primary areas:
- the acceleration of FDA’s vision to improve the regulatory process;
- the need to strengthen the research and development infrastructure so it is second to none; and
- continued encouragement of innovation by addressing issues throughout the entire ecosystem.
Mussallem also drew upon Edwards’ experience with the SAPIEN transcatheter aortic heart valves to discuss the current regulatory environment in the U.S.
To learn more about the hearing, view a webcast of the event or read Mussallem’s full written comments, visit http://www.help.senate.gov/hearings/hearing/?id=97726068-5056-a032-5268-8f15ca25fd3b.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, the stylized E logo and SAPIEN are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/edwards-ceo-addresses-senate-committee-on-preserving-and-strengthening-medical-device-innovation-in-the-us-300055165.html
SOURCE Edwards Lifesciences Corporation
Help employers find you! Check out all the jobs and post your resume.
